McNicoll Lewis & Vlak Upgrades Affymax, Inc. (AFFY) to Buy; Increased Confidence for Hematide Approval in Dialysis
Tweet Send to a Friend
McNicoll Lewis & Vlak upgraded Affymax, Inc. (NASDAQ: AFFY) from Hold to Buy. PT $12.
MLV analyst says, "Based on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
MLV analyst says, "Based on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
